SEP 10, 2026 · JOURNAL ARTICLE
Molecular subgroups and biomarker guided precision immunotherapy in triple-negative breast cancer: advances, challenges, and future directions
Frontiers in Immunology
A comprehensive review integrating evidence from trials and biomarker studies to propose a precision immunotherapy framework for TNBC, addressing current standards and unresolved clinical challenges.